Response of a patient with Lewy-body dementia to risperidone

Advances in Therapy

Volumn 15, Issue 4, 1998, Pages 194-196

  Hussain, M F ^a  

^a KENT AND MEDWAY NHS AND SOCIAL CARE PARTNERSHIP TRUST   (United Kingdom)

Author keywords

Antipsychotic; Dementia; Lewy body; Risperidone

Indexed keywords

AMITRIPTYLINE; CLOMIPRAMINE; LOFEPRAMINE; RISPERIDONE; TEMAZEPAM; TRIFLUOPERAZINE;

ADULT; ARTICLE; AUDITORY STIMULATION; CASE REPORT; DEMENTIA; DEPTH PERCEPTION; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; HUMAN; INTELLIGENCE TEST; LANGUAGE ABILITY; LEWY BODY; MALE; VISUAL HALLUCINATION; VISUAL MEMORY;

EID: 0031685021     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Ayd FJ. Risperidone: lessons learned 1984-1995. Int Drug Ther Newslett. 1995;30(2):5-12.
2. Freeman HL. Drug development report (11). Clinical issues in the use of risperidone. J Drug Devel. 1994:6:153-157.
3. Grant S, Fitton A. Risperidone: a review of its pharmacology and therapeutic potential in the treatment of schizophrenia. Drugs. 1994;48:253-273.
4. Livingston MG. Risperidone. Lancet. 1994;343:457-460.
5. Freeman HL, ed. Case History Series: Risperidone. J Drug Devel. (Case History Series No. 1) 1994:1-4.
6. McKeith I, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. Br Med J. 1992;305:673-678.
7. Lee H, Cooney JM, Lawlor BA. The use of risperidone, an atypical neuroleptic, in Lewy body disease. Int J Geriatr Psychiatry. 1994;9:415-417.
8. Allen RL, Walker Z, D'Ath PJ, Katona CLE. Risperidone for psychotic and behavioral symptoms in Lewy body dementia. Lancet. 1995;346:185.